Global Pharmaceutical & Biotechnology Environmental Monitoring

Pharmaceutical & Biotechnology Environmental Monitoring Comprehensive Study by Type (Monitoring Equipment, Media, Software, Microbiology Services), Application (Pharmaceutical Industry, Biotechnology Industry, Academic & Research Institutes) Players and Region - Global Market Outlook to 2026

Pharmaceutical & Biotechnology Environmental Monitoring Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Pharmaceutical & Biotechnology Environmental Monitoring Market Overview:
Pharmaceutical & biotechnology environmental monitoring is the crucial part of the manufacturing process in order to indicate that the microbial and particulate content of all clean room air and work surfaces are below acceptable levels. It also represents a vital means by which the effectiveness of contamination control measures can be assessed and the specific threats to the purity of products being manufactured can be identified.

Growth Drivers
  • The Stringent Government Regulations Regarding Manufacturing process of Pharmaceutical & Biotechnological Products
  • The Growing Pharmaceutical & Biotechnology Industry Worldwide
  • The Rising Cases of Microbial Contamination & Product Recalls


Opportunities
  • The Emerging Demand from Economies

Challenges
  • Maintaining Sterility or Purity of the Desired Organism


Competitive Landscape:

Some of the key players profiled in the report are Danaher Corporation (United States), Thermo Fisher Scientific (United States), Merck KGaA (Germany), Sinensis Life Sciences B.V. (Netherlands), Lonza Group Ltd (Switzerland), Biomerieux (United States), Veltek Associates, Inc. (United States), Cosasco (United States), RMONI (Belgium), Amphenol Advanced Sensors (Germany) and Vaisala (Finland). Analyst at AMA Research see United States Players to retain maximum share of Global Pharmaceutical & Biotechnology Environmental Monitoring market by 2026.

On 2 April 2019, G-CON Manufacturing, the leader in prefabricated, flexible cleanroom solutions, and Veltek Associates, a leader in solutions for the control of particulate and microbial contamination, announced that the two companies have signed a distribution agreement whereby G-CON will distribute Veltek’s cleanroom products systems and services to G-CON’s customers. Through this relationship, G-CON and Veltek will be able to provide a turnkey prefabricated cleanroom, cleaning products, gowning materials, cleanroom equipment, and cleanroom expertise.

What Can be Explored with the Pharmaceutical & Biotechnology Environmental Monitoring Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Pharmaceutical & Biotechnology Environmental Monitoring Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Pharmaceutical & Biotechnology Environmental Monitoring
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Pharmaceutical & Biotechnology Environmental Monitoring market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Pharmaceutical & Biotechnology Environmental Monitoring market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Environmental Monitoring Equipment Manufacturers, Environmental Monitoring Equipment Traders/Distributors, Environmental Monitoring Equipment Importer/Exporter, Software Providers, Services Providers, Regulatory & Government Bodies, End Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Monitoring Equipment
  • Media
  • Software
  • Microbiology Services
By Application
  • Pharmaceutical Industry
  • Biotechnology Industry
  • Academic & Research Institutes
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Stringent Government Regulations Regarding Manufacturing process of Pharmaceutical & Biotechnological Products
      • 3.2.2. The Growing Pharmaceutical & Biotechnology Industry Worldwide
      • 3.2.3. The Rising Cases of Microbial Contamination & Product Recalls
    • 3.3. Market Challenges
      • 3.3.1. Maintaining Sterility or Purity of the Desired Organism
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Environmental Monitoring Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical & Biotechnology Environmental Monitoring, by Type, Application and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical & Biotechnology Environmental Monitoring (Value)
      • 5.2.1. Global Pharmaceutical & Biotechnology Environmental Monitoring by: Type (Value)
        • 5.2.1.1. Monitoring Equipment
        • 5.2.1.2. Media
        • 5.2.1.3. Software
        • 5.2.1.4. Microbiology Services
      • 5.2.2. Global Pharmaceutical & Biotechnology Environmental Monitoring by: Application (Value)
        • 5.2.2.1. Pharmaceutical Industry
        • 5.2.2.2. Biotechnology Industry
        • 5.2.2.3. Academic & Research Institutes
      • 5.2.3. Global Pharmaceutical & Biotechnology Environmental Monitoring Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Pharmaceutical & Biotechnology Environmental Monitoring: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Danaher Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck KGaA (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sinensis Life Sciences B.V. (Netherlands)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Lonza Group Ltd (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Biomerieux (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Veltek Associates, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cosasco (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. RMONI (Belgium)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Amphenol Advanced Sensors (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Vaisala (Finland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Pharmaceutical & Biotechnology Environmental Monitoring Sale, by Type, Application and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical & Biotechnology Environmental Monitoring (Value)
      • 7.2.1. Global Pharmaceutical & Biotechnology Environmental Monitoring by: Type (Value)
        • 7.2.1.1. Monitoring Equipment
        • 7.2.1.2. Media
        • 7.2.1.3. Software
        • 7.2.1.4. Microbiology Services
      • 7.2.2. Global Pharmaceutical & Biotechnology Environmental Monitoring by: Application (Value)
        • 7.2.2.1. Pharmaceutical Industry
        • 7.2.2.2. Biotechnology Industry
        • 7.2.2.3. Academic & Research Institutes
      • 7.2.3. Global Pharmaceutical & Biotechnology Environmental Monitoring Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical & Biotechnology Environmental Monitoring: by Type(USD Million)
  • Table 2. Pharmaceutical & Biotechnology Environmental Monitoring Monitoring Equipment , by Region USD Million (2015-2020)
  • Table 3. Pharmaceutical & Biotechnology Environmental Monitoring Media , by Region USD Million (2015-2020)
  • Table 4. Pharmaceutical & Biotechnology Environmental Monitoring Software , by Region USD Million (2015-2020)
  • Table 5. Pharmaceutical & Biotechnology Environmental Monitoring Microbiology Services , by Region USD Million (2015-2020)
  • Table 6. Pharmaceutical & Biotechnology Environmental Monitoring: by Application(USD Million)
  • Table 7. Pharmaceutical & Biotechnology Environmental Monitoring Pharmaceutical Industry , by Region USD Million (2015-2020)
  • Table 8. Pharmaceutical & Biotechnology Environmental Monitoring Biotechnology Industry , by Region USD Million (2015-2020)
  • Table 9. Pharmaceutical & Biotechnology Environmental Monitoring Academic & Research Institutes , by Region USD Million (2015-2020)
  • Table 10. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2015-2020)
  • Table 11. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 12. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 13. Brazil Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 14. Brazil Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 15. Argentina Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 16. Argentina Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 17. Rest of South America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 18. Rest of South America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 19. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2015-2020)
  • Table 20. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 21. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 22. China Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 23. China Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 24. Japan Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 25. Japan Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 26. India Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 27. India Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 28. South Korea Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 29. South Korea Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 30. Taiwan Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 31. Taiwan Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 32. Australia Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 33. Australia Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 35. Rest of Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 36. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2015-2020)
  • Table 37. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 38. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 39. Germany Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 40. Germany Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 41. France Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 42. France Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 43. Italy Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 44. Italy Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 45. United Kingdom Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 46. United Kingdom Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 47. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 48. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 49. Rest of Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 50. Rest of Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 51. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2015-2020)
  • Table 52. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 53. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 54. Middle East Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 55. Middle East Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 56. Africa Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 57. Africa Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 58. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2015-2020)
  • Table 59. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 60. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 61. United States Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 62. United States Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 63. Canada Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 64. Canada Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 65. Mexico Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2015-2020)
  • Table 66. Mexico Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2015-2020)
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Pharmaceutical & Biotechnology Environmental Monitoring: by Type(USD Million)
  • Table 79. Pharmaceutical & Biotechnology Environmental Monitoring Monitoring Equipment , by Region USD Million (2021-2026)
  • Table 80. Pharmaceutical & Biotechnology Environmental Monitoring Media , by Region USD Million (2021-2026)
  • Table 81. Pharmaceutical & Biotechnology Environmental Monitoring Software , by Region USD Million (2021-2026)
  • Table 82. Pharmaceutical & Biotechnology Environmental Monitoring Microbiology Services , by Region USD Million (2021-2026)
  • Table 83. Pharmaceutical & Biotechnology Environmental Monitoring: by Application(USD Million)
  • Table 84. Pharmaceutical & Biotechnology Environmental Monitoring Pharmaceutical Industry , by Region USD Million (2021-2026)
  • Table 85. Pharmaceutical & Biotechnology Environmental Monitoring Biotechnology Industry , by Region USD Million (2021-2026)
  • Table 86. Pharmaceutical & Biotechnology Environmental Monitoring Academic & Research Institutes , by Region USD Million (2021-2026)
  • Table 87. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2021-2026)
  • Table 88. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 89. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 90. Brazil Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 91. Brazil Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 92. Argentina Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 93. Argentina Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 94. Rest of South America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 95. Rest of South America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 96. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2021-2026)
  • Table 97. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 98. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 99. China Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 100. China Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 101. Japan Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 102. Japan Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 103. India Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 104. India Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 105. South Korea Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 106. South Korea Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 107. Taiwan Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 108. Taiwan Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 109. Australia Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 110. Australia Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 111. Rest of Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 112. Rest of Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 113. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2021-2026)
  • Table 114. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 115. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 116. Germany Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 117. Germany Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 118. France Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 119. France Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 120. Italy Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 121. Italy Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 122. United Kingdom Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 123. United Kingdom Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 124. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 125. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 126. Rest of Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 127. Rest of Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 128. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2021-2026)
  • Table 129. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 130. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 131. Middle East Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 132. Middle East Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 133. Africa Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 134. Africa Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 135. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2021-2026)
  • Table 136. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 137. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 138. United States Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 139. United States Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 140. Canada Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 141. Canada Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 142. Mexico Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2021-2026)
  • Table 143. Mexico Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2021-2026)
  • Table 144. Research Programs/Design for This Report
  • Table 145. Key Data Information from Secondary Sources
  • Table 146. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical & Biotechnology Environmental Monitoring: by Type USD Million (2015-2020)
  • Figure 5. Global Pharmaceutical & Biotechnology Environmental Monitoring: by Application USD Million (2015-2020)
  • Figure 6. South America Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 7. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 8. Europe Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 9. MEA Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 10. North America Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 11. Global Pharmaceutical & Biotechnology Environmental Monitoring share by Players 2020 (%)
  • Figure 12. Global Pharmaceutical & Biotechnology Environmental Monitoring share by Players (Top 3) 2020(%)
  • Figure 13. Global Pharmaceutical & Biotechnology Environmental Monitoring share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 16. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 17. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 18. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 19. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Merck KGaA (Germany) Revenue: by Geography 2020
  • Figure 21. Sinensis Life Sciences B.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 22. Sinensis Life Sciences B.V. (Netherlands) Revenue: by Geography 2020
  • Figure 23. Lonza Group Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Lonza Group Ltd (Switzerland) Revenue: by Geography 2020
  • Figure 25. Biomerieux (United States) Revenue, Net Income and Gross profit
  • Figure 26. Biomerieux (United States) Revenue: by Geography 2020
  • Figure 27. Veltek Associates, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Veltek Associates, Inc. (United States) Revenue: by Geography 2020
  • Figure 29. Cosasco (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cosasco (United States) Revenue: by Geography 2020
  • Figure 31. RMONI (Belgium) Revenue, Net Income and Gross profit
  • Figure 32. RMONI (Belgium) Revenue: by Geography 2020
  • Figure 33. Amphenol Advanced Sensors (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Amphenol Advanced Sensors (Germany) Revenue: by Geography 2020
  • Figure 35. Vaisala (Finland) Revenue, Net Income and Gross profit
  • Figure 36. Vaisala (Finland) Revenue: by Geography 2020
  • Figure 37. Global Pharmaceutical & Biotechnology Environmental Monitoring: by Type USD Million (2021-2026)
  • Figure 38. Global Pharmaceutical & Biotechnology Environmental Monitoring: by Application USD Million (2021-2026)
  • Figure 39. South America Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 40. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 41. Europe Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 42. MEA Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 43. North America Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Danaher Corporation (United States)
  • Thermo Fisher Scientific (United States)
  • Merck KGaA (Germany)
  • Sinensis Life Sciences B.V. (Netherlands)
  • Lonza Group Ltd (Switzerland)
  • Biomerieux (United States)
  • Veltek Associates, Inc. (United States)
  • Cosasco (United States)
  • RMONI (Belgium)
  • Amphenol Advanced Sensors (Germany)
  • Vaisala (Finland)
Select User Access Type

Key Highlights of Report


Jun 2021 206 Pages 80 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pharmaceutical & Biotechnology Environmental Monitoring Quantitative research analysis
Global Pharmaceutical & Biotechnology Environmental Monitoring Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Pharmaceutical & Biotechnology Environmental Monitoring market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Pharmaceutical & Biotechnology Environmental Monitoring market are Danaher Corporation (United States), Thermo Fisher Scientific (United States), Merck KGaA (Germany), Sinensis Life Sciences B.V. (Netherlands), Lonza Group Ltd (Switzerland), Biomerieux (United States), Veltek Associates, Inc. (United States), Cosasco (United States), RMONI (Belgium), Amphenol Advanced Sensors (Germany) and Vaisala (Finland), to name a few.
"Technological Advancements in Environmental Monitoring Products" is seen as one of major influencing trends for Pharmaceutical & Biotechnology Environmental Monitoring Market during projected period 2020-2026.

Know More About Global Pharmaceutical & Biotechnology Environmental Monitoring Report?

Have a Query? Click Here

Other Related Reports

Allergy Medicine Comprehensive Study by Type (Tablet, Liquid), Allergy (Drug Allergy, Food Allergy, Skin Allergy, Insect Allergy, Latex Allergy, Others), Symptoms (Hives, Fever) Players and Region -...
$ 3500
Metronidazole Comprehensive Study by Type (Metronidazole Tablets, Metronidazole Capsule, Metronidazole Injection, Others), Application (Anaerobic Bacterial Infections, Sexually Transmitted Disease, B...
$ 3750
Botox Comprehensive Study by Type (Botulinum Toxin Type A, Botulinum Toxin Type B), Application (Aesthetic Use, Therapeutics Use), End User (Clinics) Players and Region - Global Market Outlook to 202...
$ 3500
Wound Care Dressing Comprehensive Study by Type (Hydrocolloid, Hydrogel, Alginate, Collagen, Others), Application (Acute wounds, Chronic Wounds, Surgical Wounds) Players and Region - Global Market Ou...
$ 3500
Intravenous Iron Drugs Comprehensive Study by Type (Ferric Gluconate, Ferric Carboxyl Maltose, Iron Sucrose, Iron Dextran), Application (Adult, Paediatric), Distribution Channel (Hospital Pharmacies,...
$ 3650
Calcium Tablets Comprehensive Study by Type (Effervescent Tablets, Chewable Tablets, Sublingual Tablets, Enteric Coated Tablets), Purchase Pattern (OTC, Prescription), Distribution Channel (Retail Ph...
$ 3650